Floatz logo

Therapeutic Asset Ratings

3,229 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tirzepatide
Coronary Artery Disorder
JULIO GRANADOS MONTIELP4BB (65)
Tirzepatide
Coronary Microvascular Disorder
Tina VilsbøllP4BB (65)
Tirzepatide
Acquired Hypothalamic Obesity
Grace KimP4BB (65)
Tirzepatide
Musculoskeletal System Disorder
Pennington Biomedical Research CenterP4BB (65)
Tirzepatide
Osteoarthritis, Knee
JULIO GRANADOS MONTIELP4BB (65)
Tirzepatide
Osteoporosis
Pennington Biomedical Research CenterP4BB (65)
Tirzepatide
Polycystic Ovary Syndrome
University of BonnP4BB (65)
Tirzepatide
Prader-Willi Syndrome
Grace KimP4BB (65)
Tislelizumab
Hepatocellular Carcinoma
Haibo ShaoP4BB (65)
Tislelizumab
Small Cell Lung Carcinoma
BeOne MedicinesP4BB (65)
Topiramate
Meniere Disease
University of California, IrvineP4BB (65)
Toremifene
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP4BB (65)
Toremifene
Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP4BB (65)
Trametinib
Anaplastic Astrocytoma
National Cancer Institute (NCI)P4BB (65)
Trametinib
Angiocentric Glioma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Astrocytic Tumor
Novartis PharmaceuticalsP4BB (65)
Trametinib
Central Neurocytoma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Cerebellar Liponeurocytoma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Chordoid Glioma Of The Third Ventricle
Novartis PharmaceuticalsP4BB (65)
Trametinib
Desmoplastic Infantile Astrocytoma/Ganglioglioma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Diffuse Astrocytoma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Lhermitte-Duclos Disease
Novartis PharmaceuticalsP4BB (65)
Trametinib
Extraventricular Neurocytoma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Gangliocytoma
Novartis PharmaceuticalsP4BB (65)
Trametinib
Ganglioglioma
Novartis PharmaceuticalsP4BB (65)
Showing 2126 to 2150 of 3,229 assets
PreviousPage 86 of 130Next